Anand Varadan

2018 - Karyopharm Therapeutics

In 2018, Anand Varadan earned a total compensation of $2.3M as Executive Vice President, Chief Commercial Officer at Karyopharm Therapeutics.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$102,263
Option Awards$1,951,950
Salary$211,846
Other$11,358
Total$2,302,417

Varadan received $2M in option awards, accounting for 85% of the total pay in 2018.

Varadan also received $25K in bonus, $102.3K in non-equity incentive plan, $211.8K in salary and $11.4K in other compensation.

Rankings

In 2018, Anand Varadan's compensation ranked 5,022nd out of 14,244 executives tracked by ExecPay. In other words, Varadan earned more than 64.7% of executives.

ClassificationRankingPercentile
All
5,022
out of 14,244
65th
Division
Manufacturing
1,887
out of 5,765
67th
Major group
Chemicals And Allied Products
693
out of 2,128
67th
Industry group
Drugs
580
out of 1,817
68th
Industry
Pharmaceutical Preparations
446
out of 1,391
68th
Source: SEC filing on April 19, 2019.

Varadan's colleagues

We found four more compensation records of executives who worked with Anand Varadan at Karyopharm Therapeutics in 2018.

2018

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2018

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2018

Christopher Primiano

Karyopharm Therapeutics

General Counsel

2018

Michael MSM

Karyopharm Therapeutics

Chief Financial Officer

News

In-depth

You may also like